State Street Corp Sangamo Therapeutics, Inc Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

A detailed history of State Street Corp transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, State Street Corp holds 664,621 shares of SGMO stock, worth $1.36 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
664,621
Previous 519,221 28.0%
Holding current value
$1.36 Million
Previous $186,000 206.99%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$0.32 - $1.1 $46,528 - $159,940
145,400 Added 28.0%
664,621 $571,000
Q2 2024

Aug 14, 2024
SELL
$0.36 - $0.65 $803,729 - $1.45 Million
-2,232,583 Reduced 81.13%
519,221 $186,000
Q1 2024

May 15, 2024
BUY
$0.42 - $1.38 $18,243 - $59,941
43,436 Added 1.6%
2,751,804 $1.84 Million
Q4 2023

Feb 14, 2024
BUY
$0.3 - $0.63 $6,684 - $14,038
22,283 Added 0.83%
2,708,368 $1.46 Million
Q3 2023

Nov 14, 2023
BUY
$0.58 - $1.47 $17,665 - $44,773
30,458 Added 1.15%
2,686,085 $1.61 Million
Q2 2023

Aug 14, 2023
SELL
$1.11 - $1.74 $7 Million - $11 Million
-6,304,951 Reduced 70.36%
2,655,627 $3.45 Million
Q1 2023

May 15, 2023
SELL
$1.66 - $3.67 $1.37 Million - $3.04 Million
-828,306 Reduced 8.46%
8,960,578 $15.8 Million
Q4 2022

Feb 14, 2023
BUY
$2.77 - $5.07 $7.81 Million - $14.3 Million
2,820,608 Added 40.48%
9,788,884 $30.7 Million
Q3 2022

Nov 15, 2022
SELL
$4.27 - $6.39 $3.29 Million - $4.93 Million
-771,195 Reduced 9.96%
6,968,276 $34.1 Million
Q2 2022

Aug 15, 2022
SELL
$3.28 - $6.21 $117,607 - $222,665
-35,856 Reduced 0.46%
7,739,471 $32 Million
Q1 2022

May 16, 2022
BUY
$5.23 - $7.82 $8.21 Million - $12.3 Million
1,570,740 Added 25.32%
7,775,327 $45.2 Million
Q4 2021

Feb 14, 2022
BUY
$7.29 - $10.97 $2.44 Million - $3.67 Million
334,832 Added 5.7%
6,204,587 $46.5 Million
Q3 2021

Nov 15, 2021
SELL
$9.01 - $12.01 $1.12 Million - $1.49 Million
-124,411 Reduced 2.08%
5,869,755 $52.9 Million
Q2 2021

Aug 16, 2021
SELL
$10.17 - $12.64 $5.58 Million - $6.93 Million
-548,501 Reduced 8.38%
5,994,166 $71.8 Million
Q1 2021

May 17, 2021
BUY
$10.88 - $17.05 $1.8 Million - $2.82 Million
165,610 Added 2.6%
6,542,667 $82 Million
Q4 2020

Feb 16, 2021
SELL
$9.23 - $18.18 $5.98 Million - $11.8 Million
-648,110 Reduced 9.23%
6,377,057 $99.5 Million
Q3 2020

Nov 10, 2020
BUY
$9.38 - $12.48 $5.03 Million - $6.69 Million
536,249 Added 8.26%
7,025,167 $66.4 Million
Q2 2020

Aug 14, 2020
BUY
$6.21 - $11.83 $10.2 Million - $19.4 Million
1,641,150 Added 33.85%
6,488,918 $58.1 Million
Q1 2020

May 11, 2020
BUY
$5.05 - $8.85 $24.5 Million - $42.9 Million
4,847,768 New
4,847,768 $30.9 Million

Others Institutions Holding SGMO

# of Institutions
114
Shares Held
56.3M
Call Options Held
576K
Put Options Held
1.17M
View Full List

About SANGAMO THERAPEUTICS, INC

SGMO Quotes by TradingView
  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $321M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email